← Eichor
Condition: Cystinosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cystinosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
Phase N/A · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT06213402Development of Health-related Quality of Life Instrument for Patients With Cystinosis
Phase N/A · 1 location(s) · Cystinose Stiftung · NCT05959668CYSTEA-BONE Clinical Study
Phase N/A · 13 location(s) · Hospices Civils de Lyon · NCT03919981Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From
Phase 1/Phase 2 · 1 location(s) · Alice Bertaina · NCT05508009Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168European Cystinosis Cohort
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05901077Use of Cysteamine in the Treatment of Cystinosis
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT00359684National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852DFT383 in Pediatric Participants With Nephropathic Cystinosis
Phase 1/Phase 2 · 4 location(s) · Novartis Pharmaceuticals · NCT06910813
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.